Shavkatjon Azizov

Dr. Shavkatjon Azizov

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 December 2020 in Nanomaterials
Verified
Journal Article
Open access
PDF file
STSalah M. Tawfik
Salah M. Tawfik
SAShavkatjon Azizov
Shavkatjon Azizov
MEMohamed R. Elmasry
Mohamed R. Elmasry
MSMirkomil Sharipov
Mirkomil Sharipov
YLYong-Ill Lee
Yong-Ill Lee
The efficient and selective delivery of therapeutic drugs to the target site remains the main obstacle in the development of new drugs and therapeutic interventions. Up until today, nanomicelles have shown their prospective as nanocarriers for drug delivery owing to their small size, good biocompatibility, and capacity to effectively entrap lipophilic drugs in their core. Nanomicelles are formed via self-assembly in aqueous media of amphiphilic molecules into well-organized supramolecular structures. Molecular weights and structure of the core and corona forming blocks are important properties that will determine the size of nanomicelles and their shape. Selective delivery is achieved via novel design of various stimuli-responsive nanomicelles that release drugs based on endogenous or exogenous stimulations such as pH, temperature, ultrasound, light, redox potential, and others. This review summarizes the emerging micellar nanocarriers developed with various designs, their outstanding properties, and underlying principles that grant targeted and continuous drug delivery. Finally, future perspectives, and challenges for nanomicelles are discussed based on the current achievements and remaining issues.

20 February 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
M K ShuklaM K Shukla
M K Shukla
HTHarshita Tiwari
Harshita Tiwari
Rachna VermaRachna Verma
Rachna Verma
WDWen-Liang Dong
Wen-Liang Dong
SAShavkatjon Azizov
Shavkatjon Azizov
Deepak KumarDeepak Kumar
Deepak Kumar
Advancements in the fields of ionic liquids (ILs) broaden its applications not only in traditional use but also in different pharmaceutical and biomedical fields. Ionic liquids “Solutions for Your Success” have received a lot of interest from scientists due to a myriad of applications in the pharmaceutical industry for drug delivery systems as well as targeting different diseases. Solubility is a critical physicochemical property that determines the drug’s fate at the target site. Many promising drug candidates fail in various phases of drug research due to poor solubility. In this context, ionic liquids are regarded as effective drug delivery systems for poorly soluble medicines. ILs are also able to combine different anions/cations with other cations/anions to produce salts that satisfy the concept behind the ILs. The important characteristics of ionic liquids are the modularity of their physicochemical properties depending on the application. The review highlights the recent advancement and further applications of ionic liquids to deliver drugs in the pharmaceutical and biomedical fields.

26 July 2022 in Polymers
Verified
Journal Article
Open access
PDF file
AKArun Kumar
Arun Kumar
MSMirkomil Sharipov
Mirkomil Sharipov
ATAbbaskhan Turaev
Abbaskhan Turaev
SAShavkatjon Azizov
Shavkatjon Azizov
IAIsmatdjan Azizov
Ismatdjan Azizov
SPSadanand Pandey
Sadanand Pandey
Globally, cancer is affecting societies and is becoming an important cause of death. Chemotherapy can be highly effective, but it is associated with certain problems, such as undesired targeting and multidrug resistance. The other advanced therapies, such as gene therapy and peptide therapy, do not prove to be effective without a proper delivery medium. Polymer-based hybrid nanoarchitectures have enormous potential in drug delivery. The polymers used in these nanohybrids (NHs) provide them with their distinct properties and also enable the controlled release of the drugs. This review features the recent use of polymers in the preparation of different nanohybrids for cancer therapy published since 2015 in some reputed journals. The polymeric nanohybrids provide an advantage in drug delivery with the controlled and targeted delivery of a payload and the irradiation of cancer by chemotherapeutical and photodynamic therapy.